9
landing page
Building Nonprofit Capacity
Since FasterCures’ inception in 2003, we have emphasized the importance of putting patients at the c
enter of the biomedical research system.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
report
A Global Early Warning System for Pandemics: Perspectives from the Front Lines
The COVID-19 pandemic exposed critical gaps in the world’s ability to detect, track, and analyze pa
ndemic threats.
+ Read More
article
Food and Drug Administration (FDA) - Patient Perspectives on Gene Therapy Products
Submitted electronically
Division of Dockets Management (HFA-305)
Food and Drug Administration
Dock
et No: FDA-2022-N-2394
5630 Fishers Lane
Room 1061
Rockville, MD 20852
+ Read More
article
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package
The Milken Institute applauds Congress on the passage of the FY2023 Omnibus Appropriations bill.
article
TRAIN Newsletter — December 2022
TRAIN eNews is delivered directly to organizations that take part in The Research Acceleration and I
nnovation Network (TRAIN).
+ Read More
article
End of Year Legislative Package – Health Provisions
Submitted electronically
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More